Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa have not yet been published in peer reviews) in IVF-intracyto- Haro 7, 6 iz, 48013 Bilbao, Spain. plasmic sperm injection (ICSI), it was concluded that the E-mail: rmatorras@hcru.osakidetza.net pregnancy rate (PR) was statistically higher with rFSH than A randomized trial was carried out comparing recombinant with urinary FSH. However, these aspects have not been FSH (rFSH) and highly purified urinary FSH (uFSH) in analysed in IUI. The aim of our study was to evaluate the intrauterine insemination (IUI) with husbands' spermatoefficacy and the potency of rFSH compared with highly purified zoa. A total of 45 women received rFSH (139 cycles), while urinary FSH (uFSH) when used for ovarian stimulation in 46 women received uFSH (155 cycles). The starting dose infertile patients undergoing IUI. was 150 IU/day s.c., beginning on the second day, and on days 6-7 the dose was adjusted according to ovarian Materials and methods response, assessed by vaginal ultrasound and plasma oestradiol concentration. The pregnancy rate according to the tional AB, Gothenburg, Sweden), it was possible to obtain at least P < 0.001). These data indicate that, in IUI cycles, rFSH 5ϫ10 6 million motile spermatozoa/ml; (ii) failure to obtain pregnancy has a higher potency than uFSH.
Introduction
pathologies were detected in the women, some of whom had more Ovarian stimulation plays an important role in intrauterine than one condition: 22.0% mild tubal factor, 31.9% endometriosis, 12.1% ovulatory disorders, 5.5% hyperprolactinaemia, 9.9% cervical insemination (IUI) with husbands' spermatozoa. It is well factor, 17.0% uterine myomata (Ͻ4 cm), and 3.3% immunological established that gonadotrophin stimulation results in higher factor. Semen samples were obtained after 4 days of sexual abstinence pregnancy rates than does no stimulation or clomiphene and studied according to the WHO standards (WHO, 1992) , except stimulation (Tredway et al., 1990; Matorras et al., 1997; Guzik for progressive motility which was analysed following our laboratory et al., 1999) . Although until recently all available human reference values. Asthenozoospermia was defined if there were Ͻ30% FSH pharmaceutical preparations were extracted from postof progressive motile spermatozoa (Matorras et al., 1998) . The main menopausal urine, recombinant human FSH (rFSH) became male diagnoses were: oligozoospermia (4.4%), asthenozoospermia available a few years ago (Chappel et al., 1992; Olijve et al., (58.2%) , teratozoospermia (29.7%), and immunological factor (5.5%).
1996). The manufacture of rFSH has been reported to have
In all cases of male factor infertility there was asthenozoospermia, the following advantages: that production is rendered independalone or in combination with the other male conditions described ent of urine collection; that batch-to-batch consistency can be above.
The IUI method has been reported previously (Matorras et al., guaranteed; that the injection of potentially allergenic proteins 1995, 1997) . Ovarian cycle stimulation was started on the second declining oestradiol concentrations were also cancelled. If there were more than six follicles ജ17 mm diameter and/or oestradiol concentrations Ͼ2000 pg/ml, then the cycle was cancelled because of hyper-response (risk of hyperstimulation/multiple pregnancy). In patients in whom two cycles were cancelled, in the following cycles was defined by the visualization of a gestational sac at the sixth to seventh week of amenorrhoea.
a Values are reported as percentages or as mean Ϯ SD. There were no significant differences between the two patient groups.
Design of the study
The 91 couples studied were divided randomly into two groups, by means of sealed envelopes: 45 in the rFSH group (out of 163 started mia (37.8% and 21.7%) and immunological factor (2.2% and 8.7%). cycles, 24 were dropped, corresponding to 139 IUI cycles) and 46 in rFSH and uFSH groups were comparable regarding sperm characterthe uFSH group (out of 182 started cycles, 27 were dropped, istics, both in the unprepared specimen and the prepared specimens corresponding to 155 cycles). The randomization was performed by (Table I) . a person not involved in the study. Computer-generated random numbers were placed into sealed envelopes. Patients were blinded Statistical analysis with regard to the type of treatment, as were the ultrasound staff, Statistical analysis was performed by means of χ 2 , Mann-Whitney, oestradiol analysis and sperm laboratory. The prescribing gynaecotwo-tailed Fisher and Student's t tests following the standard criteria logist was not blinded. Patients were randomized at the beginning of of applicability. Pregnancy rates were tested by means of the odds the study and remained in the same treatment during all the IUI ratio (OR) and its 95% confidence interval (CI). Cumulative pregnancy cycles. The frequency of the number of cycles in each group was as rates were calculated following life- Table I .
Results

No significant differences were found between the demographic
Characteristics of both groups characteristics of the two groups (Table I) , thus suggesting Both groups were comparable with regard to the duration of infertility, that they were adequately randomized. the proportion of secondary infertility, the proportion of normal With regard to pregnancy rates, one spontaneous pregnancy women and other infertility parameters (Table II) . Nor were there occurred in one rFSH patient, after failure to obtain pregnancy any other differences in the women's characteristics. The following in one IUI cycle, another cycle being cancelled. Thus, the PR male conditions were similar in both groups: asthenozoospermia (57.8% and 58.7%), oligozoospermia (2.2% and 6.5%), teratozoosperhas been calculated both including this case (per intention to because of personal problems, one case because of failure to There were no significant differences between the two patient groups. Values in parentheses correspond to numbers of cases.
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obtain the sperm specimen, and one case because of a car accident). The number of FSH ampoules consumed in cancelled cycles control couples would be required. Similarly, under the same methodological conditions, totals of 2131 study cycles and 2131 control cycles would be required to achieve statistical treat PR) and excluding it (corrected PR) ( Table III) . The PR calculated on a per woman basis were somewhat higher in significance with regard to per cycle PR. rFSH, both on a per intention to treat basis (57.8% versus 52.2%) and on a per woman corrected PR (56.8% versus Discussion 52.2%; OR ϭ 1.20, 95% CI ϭ 0.48-3.0) and cumulative PR (69.6% versus 61.0%), but without statistical significance. The IUI with husbands' spermatozoa is a widely employed, albeit controversial technique. Although early studies reported low per cycle crude PR was 17.99% in rFSH versus 15.48% in uFSH, which again lacked statistical significance (Table II) . PR, present rates are much higher. This improvement in PR is mainly due to the use of advances in IVF methodology Nor were there differences concerning the per cycle corrected PR (18.12% versus 15.48%; OR ϭ 1.21, 95% CI ϭ 0.62-(semen preparation, ovarian stimulation, cycle monitoring) in IUI. At the present time, IUI is also being used in artificial 2.33). The first cycle PR was 28.88% (13/45) in rFSH versus 23.91% (11/46) in uFSH (not significant; OR ϭ 1.29, 95% insemination by donor (Matorras et al., 1996) . IUI is usually performed under gonadotrophin ovarian stimulation. A number CI ϭ 0.46-3.64).
With regard to ovarian cycle monitoring parameters (Table of gonadotrophin protocols have been described (Guzik et al., 1999) , but as far as we know rFSH has not been studied in a IV), there were no differences in terms of duration of stimulation, insemination day, oestradiol determinations and ultrarandomized trial. A number of theoretical clinical advantages of recombinant gonadotrophins have been reported, including sounds performed. Oestradiol concentrations were similar in both groups. The number of FSH ampoules consumed per lack of infective risk, homogeneity among batches, and avoidance of the injection of allergenic proteins. It has been cycle was lower in the rFSH group (19.20 Ϯ 7.02 versus 23.80 Ϯ 10.78; P Ͻ 0.0001); the number of follicles ജ16 mm suggested that rFSH might have a superior in-vivo activity, as better ovarian responses have been obtained in IVF cycles in diameter was also lower in the rFSH group (3.75 Ϯ 2.28 comparison with uFSH (Out et al., 1995; Bergh et al., with that reported in a meta-analysis of IVF-ICSI data (Daya and Gunby, 1999) needs to be confirmed in much larger studies. 1997; Jacob et al., 1998) . Recently, in a meta-analysis of 12 randomized trials (the majority of which have not yet been published in peer reviews) (Daya and Gunby, 1999) , rFSH References and urinary FSH (either urinary FSH or highly purified urinary Balasch, J., Fabregues, F., Peñarrubia, J. et al. (1998) Follicular development FSH) were compared in IVF-ICSI protocols, the conclusion and hormonal levels following highly purified or recombinant folliclestimulating hormone administration in ovulatory women and WHO group being made that the PR was statistically higher in rFSH than II anovulatory infertile patients. J. Assist. Reprod. Genet., 15, [552] [553] [554] [555] [556] [557] [558] [559] in uFSH.
Bergh, C., Howles, C.M., Borg, K. et al. (1997) about 20% lower in rFSH; thus, when the oestradiol/ampoules
